Publicacións en colaboración con investigadores/as de Hospital Virgen del Camino (27)

2023

  1. Disposition of Work-Related Asthma in a Spanish Asthma Cohort: Comparison of Asthma Severity Between Employed and Retired Workers

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 11, pp. 3407-3413.e1

  2. Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288

  3. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti–IL-5 Biologics: A Real-Life Study

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 1, pp. 37-44

  4. Reply to “Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies”

    Journal of Investigational Allergology and Clinical Immunology

2022

  1. Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 3, pp. 863-866.e1

2021

  1. Seaic specialty forum: Analysis of the current situation of allergology in spain and outlook for the future

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 120-131

2019

  1. Ige-mediated sensitization to galactose-α-1,3-galactose (α-gal) in urticaria and anaphylaxis in spain: Geographical variations and risk factors

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 6, pp. 436-443

  2. Quality standards for allergen immunotherapy clinics in Spain: Consensus document

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 4, pp. 272-279

2017

  1. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 72, Núm. 3, pp. 462-472

  2. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment

    Pediatric Allergy and Immunology, Vol. 28, Núm. 1, pp. 60-70

2016

  1. Allergy immunotherapy across the life cycle to promote active and healthy ageing: From research to policies

    Clinical and Translational Allergy, Vol. 6, Núm. 1

  2. Clinical performance of commercial ISAC 112 allergen microarray versus noncommercial RIRAAF platform for the diagnosis of plant food and olive pollen allergies

    Journal of Investigational Allergology and Clinical Immunology

  3. Is microarray analysis really useful and sufficient to diagnose nut allergy in the Mediterranean area?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 26, Núm. 1, pp. 31-39

  4. Is the ISAC 112 microarray useful in the diagnosis of pollinosis in Spain?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 26, Núm. 2, pp. 92-99

2015

  1. Are all new allergens in TRUE Test® essential for a baseline set?

    Contact Dermatitis

2014

  1. Allergen Immunotherapy (AIT) in Allergic Rhinitis: Long-Term Efficacy and the Development of Asthma. What Do We Know?

    Current Treatment Options in Allergy, Vol. 1, Núm. 1, pp. 14-26

  2. Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: An Allergists' Consensus

    Clinical and Translational Allergy, Vol. 4, Núm. 1

  3. Management of angioedema without urticaria in the emergency department

    Annals of Medicine, Vol. 46, Núm. 8, pp. 607-618

2013

  1. Validation of the first treatment-specific questionnaire for the assessment of patient satisfaction with allergen-specific immunotherapy in allergic patients: The ESPIA questionnaire

    Journal of Allergy and Clinical Immunology, Vol. 131, Núm. 6

2012

  1. Analysis of mite allergic patients in a diverse territory by improved diagnostic tools

    Clinical and Experimental Allergy, Vol. 42, Núm. 7, pp. 1129-1138